A study involving two patients has demonstrated the effects of botulinum toxin in improving the appearance of a facial abnormality…
Articles by Ashraf Malhas, PhD
AdipoRon, a therapy targeting the signaling pathways that involve the protein adiponectin, was able to reduce clinical features of…
Rituximab (brand name Rituxan, among others) may be effective in treating patients with diffuse systemic sclerosis, according to a French…
Patients with early diffuse cutaneous systemic sclerosis (dcSSc) endure high levels of disability, fatigue and pain, finds a new study…
A study of the gut bacterial composition in scleroderma patients identified unique bacterial alterations associated with clinical evidence of gastrointestinal disease.
Mycophenolate mofetil stabilizes the lung function of patients with systemic sclerosis-associated interstitial lung disease, or SSc-ILD, a study confirms. The stabilization…